280
Participants
Start Date
July 31, 2023
Primary Completion Date
August 31, 2026
Study Completion Date
July 31, 2027
Targeted sequencing using the GenoScreen Deeplex assay
Targeted sequencing to be performed on DNA extracted directly from clinical sputum samples using an on-demand strategy to generate a drug resistant profile. Clinicians treating the patients will have access to this and prescribe 5 or more effective drugs to the patients within 14 days of diagnosis.
University of Cape Town, Cape Town
University of Stellenbosch
OTHER
Ospedale San Raffaele
OTHER
Stichting Katholieke Universiteit
OTHER
University of Cape Town Lung Institute
OTHER
University of Cape Town
OTHER